Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Capital Reinvestment Ratio
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Capital Reinvestment Ratio of 0.24x as of March 2023, meaning it reinvests 0% of its operating cash flow (€186.97 Million) in capital expenditures (€44.48 Million). Check 2TZ goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Capital Reinvestment Ratio (2013–2025)
This chart tracks Tianjin Zhong Xin Pharmaceutical Group Corporation Limited's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Tianjin Zhong Xin Pharmaceutical Group C.
Annual Capital Reinvestment Ratio for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year Capital Reinvestment Ratio for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited from 2013 to 2025. See 2TZ FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | €461.07 Million | €118.61 Million | ▲ +101.9% |
| 2024 | 0.13x | €924.67 Million | €117.81 Million | ▼ -37.8% |
| 2023 | 0.20x | €688.49 Million | €140.93 Million | ▲ +28.5% |
| 2022 | 0.16x | €677.25 Million | €107.90 Million | ▼ -13.5% |
| 2021 | 0.18x | €852.40 Million | €156.95 Million | ▼ -34.6% |
| 2020 | 0.28x | €671.42 Million | €189.16 Million | ▼ -32.1% |
| 2019 | 0.41x | €495.49 Million | €205.61 Million | ▼ -17.4% |
| 2018 | 0.50x | €350.14 Million | €175.81 Million | ▲ +80.5% |
| 2016 | 0.28x | €417.77 Million | €116.20 Million | ▲ +8.3% |
| 2015 | 0.26x | €360.58 Million | €92.64 Million | ▲ +5.1% |
| 2014 | 0.24x | €286.85 Million | €70.15 Million | ▼ -27.9% |
| 2013 | 0.34x | €213.44 Million | €72.42 Million | — |